HomeOwner SearchCategory Search
Visit USCOA rofecoxib es a naproxen felsogastrointestinalis toxicitasanak osszehasonlitasa rheumatoid arthritises betegekben Clair Bombardier, Loren Laine, Alise Reicin, ... [et al.]

Text Registration
Copyright Title
A rofecoxib es a naproxen felsogastrointestinalis toxicitasanak osszehasonlitasa rheumatoid arthritises betegekben Clair Bombardier, Loren Laine, Alise Reicin, ... [et al.]
Status
Published
on 14 Jun 2007
Year of Creation
2001
Copyright Claimant
Massachusetts Medical Society
Registration Number
TX0005537109
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0005537109) dated 14 Jun 2007, pertains to an electronic file (eService) titled "A rofecoxib es a naproxen felsogastrointestinalis toxicitasanak osszehasonlitasa rheumatoid arthritises betegekben Clair Bombardier, Loren Laine, Alise Reicin, ... [et al.]" created in 2001. The copyright holder is Massachusetts Medical Society, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Massachusetts Medical Society.
Application Details
Registration Number
TX0005537109
Registration Date
6/14/2007
Year of Creation
2001
Agency Marc Code
DLC-CO
Record Status
Changed
Corporate Author
Massachusetts Medical Society
Notes
Host Item Entry: The New England journal of medicine, Nov. 2000, p. 1520-1528
Local Copyright Note: C.O. correspondence
Bibliographic Note: Reprint article
Material Matter Claimed Note: New Matter: Japanese translation
Previous Registration Note: English text prev. reg. 2000, TX 5-209-595
© 2025 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.